PMID: 15217958DOI: 10.1158/1078-0432.ccr-040021Jun 26, 2004Paper

Novel agents in the treatment of lung cancer: conference summary statement

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Thomas J LynchCarol S Hart

Abstract

No abstract listed.

Citations

Predicting clinical benefit in non-small-cell lung cancer patients treated with epidermal growth factor tyrosine kinase inhibitors

Jul 28, 2006·Cold Spring Harbor Symposia on Quantitative Biology·L C AmlerK J Hillan

Therapy with un-engineered naïve rat umbilical cord matrix stem cells markedly inhibits growth of murine lung adenocarcinoma

Oct 30, 2010·BMC Cancer·Dharmendra K MauryaMasaaki Tamura

Topoisomerase I inhibitor SN-38 effectively attenuates growth of human non-small cell lung cancer cell lines in vitro and in vivo.

May 26, 2011·Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer·Dharmendra Kumar MauryaMasaaki Tamura

Anticancer property of gallic acid in A549, a human lung adenocarcinoma cell line, and possible mechanisms

Feb 8, 2011·Journal of Clinical Biochemistry and Nutrition·Dharmendra K MauryaThomas Paul Asir Devasagayam

Women and lung cancer: clinical and molecular profiling as a determinate for treatment decisions: a literature review

Aug 30, 2008·Critical Reviews in Oncology/hematology·Rossana BerardiStefano Cascinu

A phase I evaluation of oral CI-1033 in combination with paclitaxel and carboplatin as first-line chemotherapy in patients with advanced non-small cell lung cancer

Apr 6, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Alberto A ChiapporiRalph Goldman Zinner

Proteasome inhibitors in lung cancer

Jan 24, 2006·Critical Reviews in Oncology/hematology·Giorgio Scagliotti

Guidelines for improving the reproducibility of quantitative multiparameter immunofluorescence measurements by laser scanning cytometry on fixed cell suspensions from human solid tumors

Dec 13, 2005·Cytometry. Part B, Clinical Cytometry·Stanley ShackneyDeborah Kociban

Epidermal growth factor receptor inhibitors in the treatment of non-small cell lung cancer

Nov 3, 2005·Expert Opinion on Emerging Drugs·Sofia Agelaki, Vassilis Georgoulias

An evaluation of pemetrexed in second-line treatment of non-small cell lung cancer

Dec 2, 2005·Expert Opinion on Pharmacotherapy·Giorgio Scagliotti

TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer

Jul 27, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstUNKNOWN TRIBUTE Investigator Group

HER2 expression as a potential marker for response to therapy targeted to the EGFR.

Apr 20, 2006·British Journal of Cancer·D R EmletS E Shackney

Lung cancer: genetics of risk and advances in chemoprevention

Jun 2, 2005·Current Opinion in Pulmonary Medicine·Robert L Keith, York E Miller

A small molecule-kinase interaction map for clinical kinase inhibitors

Feb 16, 2005·Nature Biotechnology·Miles A FabianDavid J Lockhart

Implications of EGFR PharmDx kit for cetuximab eligibility

Mar 28, 2008·Expert Review of Molecular Diagnostics·Christian Ensinger, William Sterlacci

Epidermal growth factor receptor (EGFR) mutations are exceptionally rare in thyroid transcription factor (TTF-1)-negative adenocarcinomas of the lung

Jan 17, 2015·Oncoscience·Neeta SomaiahGeorge R Simon

Mouse models of lung cancer

Jul 22, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Amit Dutt, Kwok-Kin Wong

Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features

Sep 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tatsuhiro ShibataSetsuo Hirohashi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

(opens in new tab)
The New England Journal of Medicine
Joan H SchillerEastern Cooperative Oncology Group

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected

(opens in new tab)
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Masahiro FukuokaJosé Baselga

Erlotinib in previously treated non-small-cell lung cancer

(opens in new tab)
The New England Journal of Medicine
Frances A ShepherdNational Cancer Institute of Canada Clinical Trials Group

Treatment of small cell lung cancer

(opens in new tab)
Critical Reviews in Oncology/hematology
Anupama Kurup, Nasser Hanna
ContactHelpTerms Privacy Cookies
© 2022 Meta ULC. All rights reserved